Evidence map›Paper›PMID 34673772›Full record

ArticlePLoS medicine2021

Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: A population-based cohort study.

George N Ioannou, Jacqueline M Ferguson, Ann M O'Hare, Amy S B Bohnert, Lisa I Backus, Edward J Boyko, Thomas F Osborne, Matthew L Maciejewski, C Barrett Bowling, Denise M Hynes and 4 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PLoS medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05394025 (COVID-19 Observational Research Collaboratory - Long-Term Outcomes), which is not on this map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05394025 completednot on this mapstarted 2022, after this paper: background citation

COVID-19 Observational Research Collaboratory - Long-Term Outcomes (LTO) Study

TypeobservationalSponsorVA Office of Research and DevelopmentRan2022 to 2024Enrolled479ConditionsCOVID-19, SARS-CoV-2 Infection
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

George N IoannouDivisions of Gastroenterology, Veterans Affairs Puget Sound Healthcare System and University of Washington, Seattle, Washington, United States of America.ORCID 0000-0003-1796-8977
Jacqueline M FergusonCenter for Innovation to Implementation, VA Palo Alto Healthcare System, US Department of Veterans Affairs, Palo Alto, California, United States of America.ORCID 0000-0003-0027-387X
Ann M O'HareNephrology, Veterans Affairs Puget Sound Healthcare System and University of Washington, Seattle, Washington, United States of America.
Amy S B BohnertDepartment of Psychiatry, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.ORCID 0000-0002-4426-1136
Lisa I BackusDepartment of Veterans Affairs, Population Health, Palo Alto Healthcare System, Palo Alto, California, United States of America.ORCID 0000-0001-8058-8366
Edward J BoykoGeneral Internal Medicine, Veterans Affairs Puget Sound Healthcare System and University of Washington, Seattle, Washington, United States of America.ORCID 0000-0002-3695-192X
Thomas F OsborneVeterans Affairs Palo Alto Healthcare System, Palo Alto, and Department of Radiology, Stanford University School of Medicine, Stanford, California, United States of America.ORCID 0000-0002-8896-2487
Matthew L MaciejewskiCenter of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), Durham Veterans Affairs Health Care System, Durham, North Carolina, United States of America.ORCID 0000-0003-1765-5938
C Barrett BowlingDurham Veterans Affairs Geriatric Research Education and Clinical Center, Durham Veterans Affairs Medical Center (VAMC), Durham, NC and Department of Medicine, Duke University, Durham, North Carolina, United States of America.
Denise M HynesCenter of Innovation to Improve Veteran Involvement in Care, VA Portland Healthcare System, Portland, Oregon, United States of America.
Theodore J IwashynaCenter for Clinical Management Research, VA Ann Arbor Health System, Ann Arbor, Michigan, United States of America.
Melody SaysanaResearch and Development, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, United States of America.
Pamela GreenResearch and Development, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, United States of America.
Kristin BerryResearch and Development, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, United States of America.
University of Washington · USVA Palo Alto Health Care System · USVA Puget Sound Health Care System · USDuke University · USUniversity of Michigan · USOregon State University · US

Funding

HSRD VA IK6 HX003157HSRD VA IK6 HX003395
6 · The paper itself

Abstract

backgroundWe examined whether key sociodemographic and clinical risk factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and mortality changed over time in a population-based cohort study. METHODS AND

findingsIn a cohort of 9,127,673 persons enrolled in the United States Veterans Affairs (VA) healthcare system, we evaluated the independent associations of sociodemographic and clinical characteristics with SARS-CoV-2 infection (n = 216,046), SARS-CoV-2-related mortality (n = 10,230), and case fatality at monthly intervals between February 1, 2020 and March 31, 2021. VA enrollees had a mean age of 61 years (SD 17.7) and were predominantly male (90.9%) and White (64.5%), with 14.6% of Black race and 6.3% of Hispanic ethnicity. Black (versus White) race was strongly associated with SARS-CoV-2 infection (adjusted odds ratio [AOR] 5.10, [95% CI 4.65 to 5.59], p-value <0.001), mortality (AOR 3.85 [95% CI 3.30 to 4.50], p-value < 0.001), and case fatality (AOR 2.56, 95% CI 2.23 to 2.93, p-value < 0.001) in February to March 2020, but these associations were attenuated and not statistically significant by November 2020 for infection (AOR 1.03 [95% CI 1.00 to 1.07] p-value = 0.05) and mortality (AOR 1.08 [95% CI 0.96 to 1.20], p-value = 0.21) and were reversed for case fatality (AOR 0.86, 95% CI 0.78 to 0.95, p-value = 0.005). American Indian/Alaska Native (AI/AN versus White) race was associated with higher risk of SARS-CoV-2 infection in April and May 2020; this association declined over time and reversed by March 2021 (AOR 0.66 [95% CI 0.51 to 0.85] p-value = 0.004). Hispanic (versus non-Hispanic) ethnicity was associated with higher risk of SARS-CoV-2 infection and mortality during almost every time period, with no evidence of attenuation over time. Urban (versus rural) residence was associated with higher risk of infection (AOR 2.02, [95% CI 1.83 to 2.22], p-value < 0.001), mortality (AOR 2.48 [95% CI 2.08 to 2.96], p-value < 0.001), and case fatality (AOR 2.24, 95% CI 1.93 to 2.60, p-value < 0.001) in February to April 2020, but these associations attenuated over time and reversed by September 2020 (AOR 0.85, 95% CI 0.81 to 0.89, p-value < 0.001 for infection, AOR 0.72, 95% CI 0.62 to 0.83, p-value < 0.001 for mortality and AOR 0.81, 95% CI 0.71 to 0.93, p-value = 0.006 for case fatality). Throughout the observation period, high comorbidity burden, younger age, and obesity were consistently associated with infection, while high comorbidity burden, older age, and male sex were consistently associated with mortality. Limitations of the study include that changes over time in the associations of some risk factors may be affected by changes in the likelihood of testing for SARS-CoV-2 according to those risk factors; also, study results apply directly to VA enrollees who are predominantly male and have comprehensive healthcare and need to be confirmed in other populations.

conclusionsIn this study, we found that strongly positive associations of Black and AI/AN (versus White) race and urban (versus rural) residence with SARS-CoV-2 infection, mortality, and case fatality observed early in the pandemic were ameliorated or reversed by March 2021.

Indexed as

Population SurveillanceRacial GroupsAgedCohort StudiesCOVID-19FemaleHumansMaleMiddle AgedMortalityRisk FactorsRural PopulationSocioeconomic FactorsUnited StatesUnited States Department of Veterans AffairsUrban Population

Identifiers

PMID34673772
PMCPMC8530298
OpenAlexW3207012851

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.